178 related articles for article (PubMed ID: 20478058)
1. Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage.
Kotturi MF; Botten J; Maybeno M; Sidney J; Glenn J; Bui HH; Oseroff C; Crotty S; Peters B; Grey H; Altmann DM; Buchmeier MJ; Sette A
Immunome Res; 2010 May; 6():4. PubMed ID: 20478058
[TBL] [Abstract][Full Text] [Related]
2. A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.
Kotturi MF; Botten J; Sidney J; Bui HH; Giancola L; Maybeno M; Babin J; Oseroff C; Pasquetto V; Greenbaum JA; Peters B; Ting J; Do D; Vang L; Alexander J; Grey H; Buchmeier MJ; Sette A
PLoS Pathog; 2009 Dec; 5(12):e1000695. PubMed ID: 20019801
[TBL] [Abstract][Full Text] [Related]
3. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
[TBL] [Abstract][Full Text] [Related]
4. Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.
Botten J; Sidney J; Mothé BR; Peters B; Sette A; Kotturi MF
Microbiol Mol Biol Rev; 2010 Jun; 74(2):157-70. PubMed ID: 20508245
[TBL] [Abstract][Full Text] [Related]
5. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.
Amanat F; Duehr J; Oestereich L; Hastie KM; Ollmann Saphire E; Krammer F
mSphere; 2018; 3(3):. PubMed ID: 29720525
[TBL] [Abstract][Full Text] [Related]
7. Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.
Oldstone MB; Lewicki H; Homann D; Nguyen C; Julien S; Gairin JE
J Virol; 2001 Jul; 75(14):6273-8. PubMed ID: 11413293
[TBL] [Abstract][Full Text] [Related]
8. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones.
Meulen Jt; Badusche M; Satoguina J; Strecker T; Lenz O; Loeliger C; Sakho M; Koulemou K; Koivogui L; Hoerauf A
Virology; 2004 Mar; 321(1):134-43. PubMed ID: 15033572
[TBL] [Abstract][Full Text] [Related]
9. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
[TBL] [Abstract][Full Text] [Related]
10. Protein sequence database for pathogenic arenaviruses.
Bui HH; Botten J; Fusseder N; Pasquetto V; Mothe B; Buchmeier MJ; Sette A
Immunome Res; 2007 Feb; 3():1. PubMed ID: 17288609
[TBL] [Abstract][Full Text] [Related]
11. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
12. Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses.
Mantlo E; Paessler S; Huang C
Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31581720
[TBL] [Abstract][Full Text] [Related]
13. Zoonotic aspects of arenavirus infections.
Charrel RN; de Lamballerie X
Vet Microbiol; 2010 Jan; 140(3-4):213-20. PubMed ID: 19748747
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
[TBL] [Abstract][Full Text] [Related]
15. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
[TBL] [Abstract][Full Text] [Related]
16. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production.
Xing J; Ly H; Liang Y
J Virol; 2015 Mar; 89(5):2944-55. PubMed ID: 25552708
[TBL] [Abstract][Full Text] [Related]
17. [South American Hemorrhagic Fever viruses and the cutting edge of the vaccine and antiviral development].
Lee M; Koma T; Iwasaki M; Urata S
Uirusu; 2022; 72(1):7-18. PubMed ID: 37899233
[TBL] [Abstract][Full Text] [Related]
18. Cell entry by human pathogenic arenaviruses.
Rojek JM; Kunz S
Cell Microbiol; 2008 Apr; 10(4):828-35. PubMed ID: 18182084
[TBL] [Abstract][Full Text] [Related]
19. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.
Radoshitzky SR; Abraham J; Spiropoulou CF; Kuhn JH; Nguyen D; Li W; Nagel J; Schmidt PJ; Nunberg JH; Andrews NC; Farzan M; Choe H
Nature; 2007 Mar; 446(7131):92-6. PubMed ID: 17287727
[TBL] [Abstract][Full Text] [Related]
20. High genetic divergence and recombination in Arenaviruses from the Americas.
Archer AM; Rico-Hesse R
Virology; 2002 Dec; 304(2):274-81. PubMed ID: 12504568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
